Journal article Open Access
Ayoubi, Riham;
Alshafie, Walaa;
Shapovalov, Ivan;
Greer, Peter A.;
McPherson, Peter S.;
Laflamme, Carl
<?xml version='1.0' encoding='utf-8'?> <resource xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://datacite.org/schema/kernel-4" xsi:schemaLocation="http://datacite.org/schema/kernel-4 http://schema.datacite.org/meta/kernel-4.1/metadata.xsd"> <identifier identifierType="DOI">10.5281/zenodo.5259215</identifier> <creators> <creator> <creatorName>Ayoubi, Riham</creatorName> <givenName>Riham</givenName> <familyName>Ayoubi</familyName> <nameIdentifier nameIdentifierScheme="ORCID" schemeURI="http://orcid.org/">0000-0001-6633-655X</nameIdentifier> <affiliation>Montreal Neurological Institute</affiliation> </creator> <creator> <creatorName>Alshafie, Walaa</creatorName> <givenName>Walaa</givenName> <familyName>Alshafie</familyName> <nameIdentifier nameIdentifierScheme="ORCID" schemeURI="http://orcid.org/">0000-0001-7999-1297</nameIdentifier> <affiliation>Montreal Neurological Institute</affiliation> </creator> <creator> <creatorName>Shapovalov, Ivan</creatorName> <givenName>Ivan</givenName> <familyName>Shapovalov</familyName> <affiliation>Queen's University</affiliation> </creator> <creator> <creatorName>Greer, Peter A.</creatorName> <givenName>Peter A.</givenName> <familyName>Greer</familyName> <affiliation>Queen's University</affiliation> </creator> <creator> <creatorName>McPherson, Peter S.</creatorName> <givenName>Peter S.</givenName> <familyName>McPherson</familyName> <nameIdentifier nameIdentifierScheme="ORCID" schemeURI="http://orcid.org/">0000-0001-7806-5662</nameIdentifier> <affiliation>Montreal Neurological Institute</affiliation> </creator> <creator> <creatorName>Laflamme, Carl</creatorName> <givenName>Carl</givenName> <familyName>Laflamme</familyName> <nameIdentifier nameIdentifierScheme="ORCID" schemeURI="http://orcid.org/">0000-0001-5906-025X</nameIdentifier> <affiliation>Montreal Neurological Institute</affiliation> </creator> </creators> <titles> <title>Antibody characterization report for Calpain-2 catalytic subunit</title> </titles> <publisher>Zenodo</publisher> <publicationYear>2021</publicationYear> <subjects> <subject>Calpain 2 catalytic subunit</subject> <subject>CAPN2</subject> <subject>capn2</subject> <subject>P17655</subject> <subject>antibody validation</subject> <subject>antibody characterization</subject> </subjects> <dates> <date dateType="Issued">2021-08-25</date> </dates> <language>en</language> <resourceType resourceTypeGeneral="JournalArticle"/> <alternateIdentifiers> <alternateIdentifier alternateIdentifierType="url">https://zenodo.org/record/5259215</alternateIdentifier> </alternateIdentifiers> <relatedIdentifiers> <relatedIdentifier relatedIdentifierType="DOI" relationType="IsVersionOf">10.5281/zenodo.5259214</relatedIdentifier> <relatedIdentifier relatedIdentifierType="URL" relationType="IsPartOf">https://zenodo.org/communities/treatad</relatedIdentifier> <relatedIdentifier relatedIdentifierType="URL" relationType="IsPartOf">https://zenodo.org/communities/ycharos</relatedIdentifier> </relatedIdentifiers> <rightsList> <rights rightsURI="https://creativecommons.org/licenses/by/4.0/legalcode">Creative Commons Attribution 4.0 International</rights> <rights rightsURI="info:eu-repo/semantics/openAccess">Open Access</rights> </rightsList> <descriptions> <description descriptionType="Abstract"><p>Head to head comparison of available commercial antibodies against Calpain 2 catalytic subunit by immunoblot (Western blot), immunoprecipitation and immunofluorescence.</p> <p>Work reported in this report was supported in part by the Emory-Sage-SGC TREAT-AD center established by the National Institutes of Aging under award number U54AG065187.</p></description> </descriptions> </resource>
All versions | This version | |
---|---|---|
Views | 285 | 285 |
Downloads | 180 | 180 |
Data volume | 186.2 MB | 186.2 MB |
Unique views | 249 | 249 |
Unique downloads | 169 | 169 |